Table 3 Preventive medication and vaccination use in 2014
Preventive measure | Individuals treated N (%) | Total health plan cost | Patient OOP | Total cost | PMPYa |
|---|---|---|---|---|---|
Pneumococcal vaccination | 147,552 (7.6%) | $14,142,934 | $6930 | $14,149,780 | $7.26 |
Influenza vaccination | 883,319 (45.3%) | $26,115,315 | $14,643 | $26,129,745 | $13.40 |
Total | 922,414 (47.3%) | $40,255,322 | $21,573 | $40,276,597 | $20.66 |
MI/Stroke Prevention | |||||
 Antihypertensives | 1,103,865 (56.6%) | $259,953,965 | $120,376,142 | $369,173,588 | $189.38 |
 Statins | 754,659 (38.7%) | $146,574,868 | $48,844,928 | $194,778,686 | $99.92 |
 Aspirin | 2514 (0.1%) | $11,569.57 | 8.40 | 11,573.70 | 0.01 |
 Antiplatelets | 108,899 (5.6%) | $49,170,046 | $13,925,749 | $63,053,238 | $32.35 |
 Anticoagulants | 109,114 (5.6%) | $25,344,062 | $9,197,641 | $34,451,541 | $17.67 |
 Total MI/Stroke | 1,225,741 (62.9%) | $481,054,511 | $192,344,468 | $661,468,627 | $339.33 |
 Bisphosphonates | 98,129 (5.0%) | $26,495,337 | $8,544,260 | $34,128,920 | $17.51 |
 SERMs | 11,437 (0.6%) | $12,752,847 | $3,739,518 | $16,482,842 | $8.46 |
 Denosumab | 13,567 (0.7%) | $103,203,578 | $3,602,221 | $106,801,838 | $54.79 |
 Teriparatide | 1261 (0.1%) | $10,494,134 | $1,186,876 | $11,680,624 | $5.99 |
 Total | 121,870 (6.3%) | $152,945,896 | $17,072,875 | $169,094,223 | $86.74 |